0000950170-24-007483.txt : 20240125
0000950170-24-007483.hdr.sgml : 20240125
20240125170009
ACCESSION NUMBER: 0000950170-24-007483
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231229
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davidson Michael H.
CENTRAL INDEX KEY: 0001573785
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41562
FILM NUMBER: 24563043
MAIL ADDRESS:
STREET 1: OMTHERA PHARMACEUTICALS, INC.
STREET 2: 707 STATE ROAD
CITY: PRINCETON
STATE: NJ
ZIP: 08540
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V.
CENTRAL INDEX KEY: 0001936258
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: P7
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: GOOIMEER 2-35
CITY: NARRDEN
STATE: P7
ZIP: 1411 DC
BUSINESS PHONE: 35 206 2971
MAIL ADDRESS:
STREET 1: GOOIMEER 2-35
CITY: NARRDEN
STATE: P7
ZIP: 1411 DC
FORMER COMPANY:
FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V.
DATE OF NAME CHANGE: 20220701
3/A
1
ownership.xml
3/A
X0206
3/A
2023-12-29
2023-12-29
0
0001936258
NewAmsterdam Pharma Co N.V.
NAMS
0001573785
Davidson Michael H.
C/O NEWAMSTERDAM PHARMA COMPANY N.V.
GOOIMEER 2-35
NAARDEN
P7
1411 DC
NETHERLANDS
true
true
false
false
Chief Executive Officer
Warrant (right to buy)
11.50
2022-12-22
2027-11-23
Ordinary Shares
100000
D
This amendment is being filed to include warrants to purchase ordinary shares inadvertently omitted from the Form 3 filed by the Reporting Person on December 29, 2023.
/s/ Louise Kooij by Power of Attorney for Michael H. Davidson
2024-01-25